In response to stress, p53 is accumulated and activated to induce appropriate growth inhibitory responses. This requires the release of p53 from the constraints of its negative regulators Mdm2 and Mdm4. A key event in this dissociation is the phosphorylation of p53 at threonine residue (Thr18) within the Mdm2/4-binding domain. Casein kinase 1 (CK1) plays a major role in this phosphorylation. The promyelocytic leukemia protein (PML) regulates certain modifications of p53 in response to DNA damage. Here, we investigated the role of PML in the regulation of Thr18 phosphorylation. We found that PML enhances Thr18 phosphorylation of endogenous p53 in response to stress. On DNA damage, CK1 accumulates in the cell, with a proportion concentrated in the nucleus together with p53 and PML. Furthermore, CK1 interacts with endogenous p53 and PML, and this interaction is enhanced by genotoxic stress. Inhibition of CK1 impairs the protection of p53 by PML from Mdm2-mediated degradation. Our findings support a role for PML in the regulation of p53 by CK1. We propose that following DNA damage, PML facilitates Thr18 phosphorylation by recruiting p53 and CK1 into PML nuclear bodies, thereby protecting p53 from inhibition by Mdm2, leading to p53 activation.
Introduction
In response to genotoxic stress, p53 is activated and induces growth inhibition, which is critical for tumor suppression. Under non-stress conditions, p53 stability and activity is tightly regulated, principally by two major inhibitors, Mdm2 and Mdm4 (Marine et al., 2007) . Mdm2 regulates p53 stability (Iwakuma and Lozano, 2003) , whereas Mdm4 inhibits p53 transcriptional activity. The inhibition of p53 by the Mdm proteins is relieved by multiple mechanisms, including post-translational modifications, or by physical or spatial separation (Iwakuma and Lozano, 2003) . Following DNA damage, p53 is extensively modified. Most relevant to the relief from the Mdm proteins are the phosphorylation of Ser20, Thr18 and Ser15, which reside within the highly conserved hydrophobic loop that mediates p53 binding to the Mdm proteins. These phosphorylations protect p53 from inhibition by the Mdm proteins (Lavin and Gueven, 2006) . Thr18 phosphorylation is considered the more critical of the two, as it directly attenuates its interaction with Mdm2 (Craig et al., 1999; Lai et al., 2000; Sakaguchi et al., 2000; Schon et al., 2002) . Thr18 is phosphorylated by several kinases including VRK1, Chk1, Chk2, DNA-PK (Soubeyrand et al., 2004) and casein kinase 1 (CK1) (Dumaz et al., 1999; Sakaguchi et al., 2000) . However, as these findings were based on in vitro assays, the conditions under which Thr18 phosphorylation occurs, in cultured cells, have not been established.
Casein kinase 1 is a family of serine/threonine protein kinase, consisting of multiple isoforms encoded by separate genes (CK1a, b, g1, g2, g3, d and e) and has been implicated in the regulation of various cellular functions, including membrane transport, cell division, apoptosis, chromosome segregation and the circadian rhythm (reviewed by Knippschild et al., 2005) . A CK1-related kinase in yeast, hrr25, is essential for DNA repair and can be complemented by its mammalian homologs CK1d and e isoforms (Hoekstra et al., 1994) . p53 is a substrate for both isoforms, linking them to DNA repair and cell-cycle regulation also in mammalian cells (Knippschild et al., 1997) . CK1d/e phosphorylates mouse p53 on Ser4, 6 and 9 and human p53 on Ser9 and Thr18 (reviewed by Knippschild et al., 2005) .
The regulation of the p53/Mdm2 loop through posttranslational modifications is influenced by the promyelocytic leukemia protein (PML) (Zimber et al., 2004) . Patients with acute PML undergo a t(15;17) translocation and generate the fusion protein PML/retinoic acid receptor a (reviewed by Salomoni and Pandolfi, 2002) . PML is an essential component of 'nuclear bodies,' which have been implicated in cellular processes such as tumor suppression, gene expression, post-translational modifications and proteasomal degradation (reviewed by Salomoni and Pandolfi, 2002; Zimber et al., 2004) .
We have previously shown a role of PML in the phosphorylation of p53 on Ser20 in response to DNA damage (Louria-Hayon et al., 2003) . Given the major role Thr18 phosphorylation plays in the regulation of the p53/Mdm2 loop, we investigated the participation of PML in the regulation of this phosphorylation in response to DNA damage. Here, we report a role of PML in the regulation of Thr18 phosphorylation. PML enhances the phosphorylation of p53 on Thr18 in response to genotoxic stress. Following DNA damage, CK1 interacts and colocalizes with p53 and PML. Here, we propose a role of PML in the regulation of p53 by CK1 through Thr18 phosphorylation.
Results
DNA damage induces the nuclear import of CK1, its interaction with p53 and phosphorylation of p53 on Thr18 Exposure of cells to doxorubicin (doxo; adriamycin) induces the phosphorylation of human p53 on Thr18 (Saito et al., 2003) . To determine whether this also holds true for the equivalent residue in mouse p53, Thr21, primary mouse embryo fibroblasts (MEFs) were treated with doxo (1 h), and the extent of Thr21 phosphorylation was determined at the designated time points after treatment. Endogenous p53 phosphorylation was examined by western blotting using anti-phosphoThr18/21 antibody. Thr21 phosphorylation was detected within 1 h of treatment (Figure 1a) .
Casein kinase 1 has been shown to be localized to the cytoplasm, with a distinct distribution pattern around the nucleus (Wolff et al., 2006) . We predicted that it would need to be imported to the nucleus for phosphorylating p53 in response to DNA damage. To examine this prediction, MEFs were either untreated or exposed to doxo for 1 h and the subcellular distribution of endogenous CK1 and p53 were determined by immunofluorescent analysis. In the absence of stress, (a) MEFs were either left untreated (lane 1) or treated with doxo (2 mg ml À1 ) for 1 h, washed and harvested at the indicated time points. Thr21 phosphorylation of p53 was detected by western blotting using anti-phospho-p53Thr21 antibody, and p53 levels with antimouse p53 antibody . Loading was monitored with anti-actin antibody. (b) Primary MEFs were plated on coverslips and 24 h later, were either left untreated (upper panels) or treated with doxo (2 mg ml À1 ) for 1 h (lower panels). Cells were fixed and subjected to immunofluorescent staining using anti-CK1d antibody (128A) followed by Cy5-conjugated secondary antibody (red), or anti-p53 rabbit polyclonal antibody (CM5) followed by Cy2-conjugated secondary antibody (green). Slides were visualized using a Zeiss 410 fluorescent confocal microscope ( Â 40 objective). Merged images are shown on the right, where colocalization is shown in yellow. (c) MEFs were treated as in 'a' for the indicated time points. Cell extracts were subjected to subcellular fractionation and for each time point nuclear and cytoplasmic fractions ran separately. The levels of p53 and CK1 were monitored with anti-CK1d (128A) or anti-p53 antibodies (FL-393 rabbit). The purity of the nuclear and cytoplasmic fractions was determined by detection with anti-H2B and antitubulin, respectively. (d) MEFs were either untreated or incubated with doxo (2 mg ml
À1
) for 1 h and harvested at 1 or 2 h, before subjecting to immunoprecipitation using anti-p53 goat polyclonal antibody (FL-393) followed by western blotting with anti-CK1d (128A) or anti-p53 antibodies . (e) Primary MEFs were either untreated or incubated with doxo (2 mg ml
) for 1 h, washed and harvested at 1.5 h. RNA was isolated and cDNA prepared and subjected to real-time PCR analysis. Relative mdm2 and p21 mRNA expression levels were normalized to 18S mRNA. The error bars represent an s.d. within each sample group. CK1, casein kinase 1; doxo, doxorubicin; MEFs, mouse embryo fibroblasts.
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O Alsheich-Bartok et al CK1 is principally distributed in the cytoplasm, displaying a crest around the nucleus. However, following doxo treatment, CK1 levels are elevated, and it also accumulates in the nucleus, where it partially colocalizes with p53 ( Figure 1b) . Biochemical fractionation of these cells under the same conditions confirms the preferred accumulation of CK1 and p53 in the nucleus (Figure 1c) . Thus, in response to DNA damage, p53 and CK1 accumulate in the nucleus, where they partially colocalize. These results raised the possibility that the two proteins may interact following DNA damage. To test this possibility, p53-CK1 interaction was examined in MEFs before and after doxo treatment.
As shown in Figure 1d , a clear interaction was observed between endogenous p53 and CK1d following doxo treatment, supporting the colocalization observation ( Figure 1b) . To examine whether the stress induced changes in p53 correlate with its enhanced activation, the induction of endogenous p21 and mdm2 was monitored by real-time PCR under the same experimental conditions. As shown in Figure 1d , both target genes were induced in response to doxo treatment, demonstrating that, under these stress conditions, p53 transcriptional activity was induced.
PML enhances Thr18 phosphorylation of endogenous p53 in response to DNA damage Since Thr18 phosphorylation plays a critical role in the p53-Mdm2 interaction (Craig et al., 1999; Lai et al., 2000; Schon et al., 2002) , we sought to determine whether PML regulates this phosphorylation. For this purpose, PML-deficient MEFs were reconstituted with green fluorescent protein (GFP)-PML by retroviral infection, or infected with GFP alone as a control. PML-reconstituted MEFs exhibited restored ability to form PML nuclear bodies (PML-NBs) and to activate p53 in response to DNA damage (Louria-Hayon et al., 2003) . PML-knockout and GFP-PML-reconstituted MEFs were exposed to doxo for 1 h and the phosphorylation of p53 on Thr21, and interaction with CK1 was examined by coimmunoprecipitation. To distinguish the contribution of DNA damage from the effect of p53 accumulation alone, cells were treated with the proteasome inhibitor, MG132, which elevates p53 protein levels to levels even higher than those accumulated following DNA damage. As shown in Figure 2a , constitutive expression of PML enhanced the phosphorylation of p53 on Thr21 (lane 1 versus lane 4), which was further increased by exposure to doxo (lane 3 versus lane 6), but not to MG132 (lanes 2 and 5). Consistent with this finding, the interaction between p53 and CK1 was observed in the PML-reconstituted cells even in the absence of DNA damage, and was increased following treatment. This experiment suggests that p53-CK1 binding also occurs in the absence of PML, but the presence of PML may enhance this interaction following DNA damage. To further support this finding at more physiological levels of PML, we used the acute PML-derived cell line, NB4. These cells express one allele of wild-type (wt) PML and one allele of oncogenic fusion PML-retinoic acid receptor a. The function of the wt PML is inactivated by the dominant negative fusion protein, but it can be restored by the treatment of NB4 cells with arsenic trioxide (As 2 O 3 ), which promotes PML-retinoic acid receptor a degradation and activation of the wt allele, resulting in the re-formation of PML-NBs ( Figure 2b) ; (Zhu et al., 1997; Muller et al., 1998) . NB4 cells express mutant p53 (A248G; Rizzo et al., 1998) , whose expression levels remain largely unchanged following exposure to stress. This simplifies the measurement of p53 phosphorylations without the need to normalize for changes in protein levels. To measure the effect of PML on Thr18 phosphorylation, NB4 cells were treated with As 2 O 3 (1 mM for 4 h) alone to activate PML, or together with ionizing radiation (IR, 5 Gy), to induce the phosphorylation. The extent of Thr18 phosphorylation was determined at different times after IR by western blotting using anti-phospho-p53-Thr18 antibody. Thr18 phosphorylation was detected in cells exposed to IR or As 2 O 3 alone (Figure 2c; lanes 1-3) . Importantly, the extent of phosphorylation markedly increased in response to the combined treatment of IR plus As 2 O 3 (lanes 4-7). This result suggests that activation of PML significantly enhances Thr18 phosphorylation of p53 in response to IR, supporting a role for PML in the regulation of this phosphorylation.
Functional CK1d/e is required for Thr18 phosphorylation of p53 in response to IR As outlined above, several kinases can phosphorylate p53 on Thr18 in vitro; however, the kinase responsible for this phosphorylation in vivo has not yet been identified. To determine whether CK1d/e is responsible for the observed Thr18 phosphorylation of p53 in NB4 cells, the extent of phosphorylation was compared in the presence or absence of the CK1d/e specific inhibitor, IC261 (Knippschild et al., 1997; Behrend et al., 2000; Mashhoon et al., 2000) . NB4 cells were exposed to IR (5 Gy) together with As 2 O 3 (1 mM) for 10 min in the absence or the presence of increasing amounts of IC261. Consistent with the results presented in Figure 2c , the combined treatment of IR plus As 2 O 3 led to extensive Thr18 phosphorylation (Figure 3a ; lanes 1-3) . Strikingly, treatment of cells with increasing concentrations of IC261 (3-6 mM) reduced the extent of phosphorylation significantly in a dose-dependent manner (Figure 3 , lanes 4-6). To determine whether IC261 can affect p53 phosphorylation on other sites under these conditions, the experiment was repeated but the phosphorylation on Ser15 was examined instead. Unlike the effect on Thr18 phosphorylation, IC261 had no effect on Ser15 phosphorylation (Figure 3b ), supporting the specificity of IC261 to CK1d/ e (Mashhoon et al., 2000) . This result strongly supports a role for CK1d/e in the phosphorylation of p53 on Thr18 in vivo in response to DNA damage.
PML interacts and colocalizes with CK1
To explore the mechanism by which PML enhances Thr18 phosphorylation of p53 in a CK1-dependent PML regulates the phosphorylation of p53 by CK1 O Alsheich-Bartok et al manner, we investigated whether PML interacts with CK1 in vivo. For this purpose, three different cell types were examined. First, HEK293 cells were transfected with PML-IV isoform (referred to as PML hereafter). At 48 h post-transfection, cells were harvested and subjected to coimmunoprecipitation using anti-CK1d antibody, followed by immunoblotting with anti-PML antibody. As shown in Figure 4a , a significant amount of PML was coimmunoprecipitated with endogenous CK1d. Endogenous PML was not detected in these cells, presumably due to its low expression levels (bottom panel). Second, MEFs deficient for PML (Wang et al., 1998) were transfected with Ha-CK1e and Flag-PML. Forty-eight hours later, cell extracts were subjected to coimmunoprecipitation using anti-Flag antibody followed by immunoblotting with anti-Ha antibody. CK1e was clearly coprecipitated with Flag-PML in cells coexpressing both the proteins (Figure 4b ). To determine whether this interaction also occurs between the endogenous proteins, NB4 cells were treated with As 2 O 3 and IR (5 Gy), and were collected at different times. As controls, untreated cells or cells treated with As 2 O 3 alone were used. Cell extracts were subjected to an immunoprecipitation assay using anti-CK1d antibody, followed by an anti-PML antibody. A clear interaction was observed between PML and CK1d in cells treated with both As 2 O 3 and IR, predominantly after 10 min of IR exposure (Figure 4c ). These assays demonstrate an interaction between PML and CK1 (d and e isoforms) in vivo within the range of their physiological expression levels. This interaction appears to be enhanced by DNA damage, with maximal interaction at 10 min after IR, which is consistent with the peak of Thr18 phosphorylation in these cells under the same conditions (Figure 2b) .
The above results prompted us to investigate whether CK1 is localized to the PML-NBs? To address this question, we used PML-deficient MEFs that were reconstituted with GFP-PML. These cells were treated with doxo for 1 h or were left untreated. The distribution of PML was determined by GFP fluorescence, while that of endogenous CK1d and endogenous p53 were ) for 1 h, were subjected to immunoprecipitation using anti-p53 antibody (FL-393 goat anti-mouse) followed by western blotting with anti-phospho-Thr21, antip53 (FL-393 rabbit anti-mouse) or anti-CK1d (128A) antibodies. PML levels in cells were detected with anti-GFP antibody. (b) NB4 cells were exposed to IR (5 Gy) and incubated with As 2 O 3 (1 mM) for 4 h. At the indicated time points cells were fixed in ice-cold methanol and stained for PML using anti-PML antibody (H-238, Santa Cruz Biotechnology). Slides were visualized by Olympus FV1000 microscope ( Â 60 objective, zoom 2.7). (c) NB4 cells were exposed to IR (5 Gy) and incubated with As 2 O 3 (1 mM) for 4 h. At the indicated time points, cells were harvested and subjected to western blotting. Thr18 phosphorylation of p53 was detected as in 'a' and p53 levels with anti-p53 antibodies (PAb 1801 and DO1). CK1, casein kinase 1; doxo, doxorubicin; GFP, green fluorescent protein; IR, ionizing radiation; MEF, mouse embryo fibroblasts; PML, promyelocytic leukemia protein.
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O Alsheich-Bartok et al determined by staining with anti-CK1 and anti-p53 antibodies, respectively. Stained cells were subjected to confocal laser microscopy and the staining was analysed by the Fluoview 1000 v.1.5 software. Consistent with the results in Figure 1b , treatment of cells with doxo induced p53 accumulation in the nucleus and partial nuclear accumulation of CKd. Both proteins were also found in the PML-NBs after treatment, but not in untreated cells (Figure 4d ). This result suggests that in response to DNA damage, a fraction of CK1 and p53 is localized with PML in the PML-NBs.
Inhibition of CK1d/e impairs PML protection of p53 from Mdm2
The physical interaction between PML and CK1d/e and their effect on Thr18 phosphorylation of p53, predicts that this interaction may be important for the protection of p53 from Mdm2. To test this prediction, we evaluated the role of CK1 activity in the protection of p53 from Mdm2 by PML. CK1 activity was controlled by treatment with its competitive inhibitor, IC261. H1299 cells were transfected with plasmids for p53 alone, with Mdm2 or both with increasing amounts of PML. Fortyeight hours later, cells were subjected to western blotting using anti-p53 antibody (DO1 and PAb18O1). As previously shown, Mdm2-mediated p53 degradation was inhibited by increasing the amount of PML expression plasmid (Louria-Hayon et al., 2003) ( Figure 5 ; lanes 1-5). By contrast, PML protection of p53 from Mdm2 in the presence of IC261 inhibitor was impaired (lanes 6-10). IC261 did not affect the expression levels of CK1 or Mdm2, and had a minor effect on PML levels (10% reduction) (Supplementary Figure 1) . This result supports the notion that active CK1d/e contributes to the protection of p53 from Mdm2.
Discussion
In response to stress, p53 undergoes multiple posttranslational modifications. Some of the modifications affect p53 localization and transcriptional activity, whereas certain modifications can direct p53 to a specific biological outcome, such as growth arrest versus apoptosis (reviewed by Meek, 2004; Lavin and Gueven, 2006) . However, a fundamental requirement for p53 activation is the release of p53 from inhibition by the Mdm proteins. Phosphorylation of p53 within the binding domain of the Mdm proteins plays an important role in this release (Meek, 2004) . Phosphorylation of Thr18 plays a key regulatory role in affecting the p53-mdm2 interaction (Craig et al., 1999; Lai et al., 2000; Sakaguchi et al., 2000; Schon et al., 2002) . We, therefore, investigated how this phosphorylation is regulated in response to DNA damage. We found that Thr18 phosphorylation depends on DNA damage in mouse and human cultured cells (Figures 1-3) , consistent with the previous findings (Saito et al., 2003) . Presumably, the activation of both CK1 and PML is required for this phosphorylation of p53. We further showed that this phosphorylation depends on functional CK1 by using the specific inhibitor, IC261. Since multiple isoforms of CK1 are expressed at high levels, downregulation by RNA interference is difficult to achieve (data not shown). In response to DNA damage, CK1 is accumulated and is partially imported to the nucleus. Consequently, CK1 and p53 interact physically and colocalize within the nucleus (Figure 1 ). We and others have previously shown that certain modifications of p53 are facilitated by PML. In the case of Ser20, PML facilitates the phosphorylation by interacting with and recruiting Chk2 to the PML-NBs (Louria-Hayon et al., 2003) . On this basis, we investigated whether PML also regulates Thr18 phosphorylation by CK1. We found that PML facilitates Thr18 phosphorylation in response to DNA damage (Figure 2 ). This phosphorylation is important for the protection of p53 by PML from Mdm2-mediated degradation ( Figure 5 ). To what extent this phosphorylation also protects p53 from inhibition by Mdm4 is yet to be determined. PML interacts with CK1 at physiological levels in cultured cells, and this interaction is augmented by DNA damage (Figure 4 ) and correlates with maximal phosphorylation of p53 by CK1 (Figure 2) . This interaction appears to be transient, presumably the activated proteins are redistributed to the nucleoplasm . The phosphorylation of p53 on Thr18 (a) and on Ser15 (b) was determined in separate gels. The levels of p53, CK1d and actin were detected as in Figure 2 . CK1, casein kinase 1; GFP, green fluorescent protein; IR, ionizing radiation; MEF, mouse embryo fibroblasts; PML, promyelocytic leukemia protein.
PML regulates the phosphorylation of p53 by CK1 O Alsheich-Bartok et al or may be degraded. Furthermore, PML and CK1 partially colocalize in the PML-NBs in response to doxo treatment. Taken together, our results suggest that PML facilitates Thr18 phosphorylation in response to DNA damage by interacting with p53 and CK1, and recruiting them into the PML-NBs. This mode of action of PML has been suggested for multiple modifying enzymes of p53, including HAUSP, HIPK2, CBP and hSIR2 (Langley et al., 2002; Zimber et al., 2004) . Interestingly, p53/PML and CK1 appear to be linked by positive regulatory feedback loops. PML is a direct target of p53 (de Stanchina et al., 2004) , and p53 upregulates CK1d in stress situations (Knippschild et al., 1997) . Furthermore, CK1d kinase activity is reduced in primary p53À/À lymphocytes (Maritzen et al., 2003) . Whether CK1 and PML also affect each other is yet to be explored. It is well established that p53 function is compromised in the majority of human cancers, either by direct mutations of the p53 gene, or through alternative mechanisms including elevation of Mdm proteins, or 
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Figure 4 PML interacts and colocalizes with CK1. (a) HEK293 cells were transfected with PML-IV expression plasmid (5 mg) and 48 h later cells were subjected to immunoprecipitation using anti-CK1d antibody (128A). The amount of PML in the immune complex and in the total lysate was detected using anti-PML (Sigma). (b) PML-knockout MEFs were transfected with Flag-PML-IV (5 mg) alone, or with CK1e (5 mg). Forty-eight hours later, PML was immunoprecipitated using anti-Flag M2 beads, and the amount of bound CK1e was detected with anti-Ha antibody. (c) NB4 cells were treated with As 2 O 3 (1 mM: 4 h) and IR as indicated. Cells were subjected to coimmunoprecipitation assay using anti-CK1d antibody (128A) followed by blotting with anti-PML antibody. (d) Knockout-PML MEFs reconstituted with GFP-PML were plated on slides and were either left untreated (upper panels) or treated with doxo (2 mg ml À1 for 1 h; lower panels). Cells were washed, fixed and stained for endogenous CK1d with 128A antibody followed by Cy5-conjugated secondary antibody (red), for endogenous p53 using CM5 followed by TRITC-conjugated secondary antibody (cyan) and PML was detected by GFP (green). Slides were visualized by Olympus FV1000 microscope ( Â 60 objective, zoom 1.6). CK1, casein kinase 1; doxo, doxorubicin; GFP, green fluorescent protein; IR, ionizing radiation; MEF, mouse embryo fibroblasts; PML, promyelocytic leukemia protein.
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O Alsheich-Bartok et al mutations in upstream activators, such as Chk2 and ARF. Since CK1 appears as an important upstream regulator of p53 in response to stress, it is also likely to be targeted in human cancer. Deregulated expression of CK1 has been observed in multiple cancer types. For example, elevated expression or activity of CK1 was detected in acute myeloblastic leukemia, and somatic mutations associated with increased expression of CK1e were detected in ductal carcinoma (reviewed by Knippschild et al., 2005) . Our results strongly implicate PML in the proper regulation of Thr18 phosphorylation. There is a strong link between PML and cancer development. PML-knockout mice develop tumors upon exposure to carcinogens (Wang et al., 1998) and enhance tumorigenesis in mice with partial loss of PTEN (Trotman et al., 2006) . Furthermore, a partial or complete loss of PML has been observed in multiple human cancers, including colon and prostate adenocarcinomas, breast and lung carcinomas, lymphomas, Central Nervous System tumors and germ cell tumors (Gurrieri et al., 2004) . ; Sigma Chemical Co., St Louis, MO, USA). MG132 (Calbiochem, La Jolla, CA, USA) was dissolved in DMSO and was used at 20 mM for the indicated time.
Plasmids and retroviral infection Expression plasmids used were: human wt p53 (pRC-CMV), mouse wt Mdm2 (pCOC-Mdm2 X2), human wt PML-IV (formally pCDNA3PML3), wt FLAG PML-IV (pSGS-PML) and Ha-hCK1e (pCEP4). For the production of retrovirus expressing GFP-PML, pBabe Puro GFP-PML plasmid together with CMLV helper virus plasmid were transfected into 293T cells. Retrovirus was collected from the supernatants after 48 h and used directly or stored at À70 1C. PMLknockout MEFs, derived from pmlÀ/À mice (Wang et al., 1998) were infected with the retrovirus expressing GFP-PML followed by selection with puromycin (2 mg ml À1 ).
Immunoprecipitation assay, nuclear/cytoplasmic fractionation and western blot analysis Western blot analysis and immunoprecipitation assays were carried out as described previously (Louria-Hayon et al., 2003) , with the exception that for the immunoprecipitation of Flag-PML, the lysis and washing buffers contained 0.1% NP40. Nuclear/cytoplasmic fractionation was carried out essentially as described by Sionov et al. (2001) . The antibodies used in this study were as follows: anti-human p53 monoclonal antibodies PAb1801 and DO1, anti-mouse p53 polyclonal antibodies CM5, anti-p53 goat polyclonal antibody (FL-393, AC; Santa Cruz Biotechnology, Santa Cruz, CA, USA); anti-p53 rabbit polyclonal antibody (FL-393, FC; Santa Cruz Biotechnology); anti-phospho-p53 Thr-18/21 polyclonal antibody (Saito et al., 2003) Figure 5 CK1 inhibition impaires PML protection of p53 from Mdm2-mediated degradation. (a) H1299 cells were transfected with expression plasmids for p53 alone (0.1 mg, lanes 1 and 6), or with Mdm2 (0.3 mg, lanes 2 and 7) or both together with increasing amounts of Flag-PML-IV (1 mg, lanes 3 and 8; 2 mg, lanes 4 and 9; 3 mg, lanes 5 and 10). At 48 h post-transfection samples 6-10 were treated with CK1 inhibitor IC261 (6 mM; 1 h). The p53 levels were determined with anti-p53 antibodies (PAb1802 and DO1), and GFP expression was used to monitor transfection efficiency.
(b) The amount of p53 protein levels in 'a' was quantified by densitometry and calculated relative to the levels of GFP expression (a, lower panel). The amount of the p53 protein in lanes 1 and 6 were taken as 100%, from which the amounts in lanes 2-5 and 7-10 respectively, were normalized and plotted. CK1, casein kinase 1; GFP, green fluorescent protein; PML, promyelocytic leukemia protein.
PML regulates the phosphorylation of p53 by CK1 O Alsheich-Bartok et al (Roche Applied Science, Mannheim, Germany); anti-tubulin (DM1A; Sigma); anti-histone 2B (H2B, LG2-2; a gift from Dan Eilat, Hadassah University Hospital, Jerusalem, Israel); HRP-conjugated goat anti-mouse IgG, Envision peroxidase anti-mouse or anti-rabbit (Dako Corp, Glostrup, Denmark).
Immunofluorescent staining analysis
For immunofluorescent staining, cells were plated on coverslips. Twenty-four hours later, cells were washed and fixed with 3.7% paraformaldehyde and permeabilized with 0.2% Triton X-100. CK1d was visualized by using 128A antibody, followed by goat anti-mouse Cy5-conjugated secondary antibody (Jackson ImmunoResearch Laboratories Inc., West Grove, PA, USA), p53 was visualized by CM5 antibody, followed by donkey anti-rabbit Cy2/Rhodamine (TRITC)-conjugated secondary antibody (Jackson ImmunoResearch Laboratories Inc.). PML was detected as GFP-PML. Proteins were visualized by confocal fluorescence microscopy using a Zeiss 410 microscope, (PlanApochromat Â 40), and Olympus FV1000 microscope, Â 60, using Fluview1000 v.1.5 software.
Real-time PCR assay RNA was isolated by Tri-Reagent (MRC Inc., Cincinnati, OH, USA) and cDNA was generated using M-MLV reverse transcription kit (Promega, Madison, WI, USA). Primers for real-time PCR were designed with ABI PRISM Primer Express software (Applied Biosystems, Warrington, UK).
The sequences of the primers were as follows: mouse p21: forward 5 0 -CCAGACATTCAGAGCCACAGG-3 0 , reverse 5 0 -GGTCGGACATCACCAGGATT-3 0 ; mouse mdm2: forward primer 5 0 -TGTGTTTGGAGTCCCGA-GTTT-3 0 , reverse 5 0 -GCATATATTTTCCTGTGCTCCTTCA-3; 18S: forward 5 0 -CGCCGCTAGAGG-TGAAATTC-3 0 , reverse 5 0 -CGAACC TCCGACTTTCGTTCT-3 0 . Real-time PCR was performed and samples were amplified in ABI PRISM 7500 by using SYBR-Green PCR Master Mix (Applied Biosystems) under the following conditions: 50 1C for 2 min, 95 1C for 10 min, 40 cycles at 95 1C for 15 s and 60 1C for 1 min. Gene expression was quantified using qBase software (version 1.3.5).
